The speculation and released data can intertwine t
Post# of 148243
We reduced death in critical patients by 24%.
Overall death reduction could be greater than 24%.
Surely, leronlimab prevented some severe patients from advancing to critical and then dying. LL may have prevented 100% of the severe folks who were treated with LL, from dying. (All critical patients had to move thru severe to become critical).
.
If any of the approx 107 severe patients who got SOC, died, and if none or only a fewof the approx 214 severe folks who go LL died, this data would boost overall reduction of deaths above 24%.